The crucial role of N6-methyladenosine modification in acute kidney injury: mechanisms and therapeutic potential. [PDF]
Zhang X +6 more
europepmc +1 more source
Profiles and roles of N6-methyladenosine modification in bovine oocyte maturation. [PDF]
Han T +9 more
europepmc +1 more source
N6-methyladenosine epitranscriptomic remodeling drives infantile aortic coarctation via FTO-mediated repression of PTEN and GRK5. [PDF]
Li W +6 more
europepmc +1 more source
N6-methyladenosine modification in the context of viral infection: from molecular mechanism to therapeutic potential. [PDF]
Wu X, Deng Z, Li Y, Shi C.
europepmc +1 more source
HNRM: hyperedge neighborhood-based representation for predicting N6-methyladenosine-related regulatory pathways. [PDF]
Jiang D, Li Y, Yu L.
europepmc +1 more source
Pyroptosis Regulated by N6-Methyladenosine Modification: Implications for Pyroptosis-Related Disease Therapy. [PDF]
Zhou Y +9 more
europepmc +1 more source
Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity. [PDF]
Yang J, Wan L, Chen H, Li S, Zhou Y.
europepmc +1 more source
Correction: Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts. [PDF]
Imam H +4 more
europepmc +1 more source
Statement of Retraction: N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways. [PDF]
europepmc +1 more source

